fentanyl has been researched along with Obesity in 42 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " One patient in the propofol group developed delirium compared to zero in desflurane." | 9.24 | The effect of desflurane versus propofol anesthesia on postoperative delirium in elderly obese patients undergoing total knee replacement: A randomized, controlled, double-blinded clinical trial. ( Goodman, S; Huddleston, J; Lemmens, HJ; Maloney, W; Sommer, BR; Tanaka, P, 2017) |
| "Remifentanil in combination with fentanyl is used less than fentanyl in surgical patients with hepatic impairment or obesity." | 7.81 | Remifentanil, fentanyl, or the combination in surgical procedures in the United States: predictors of use in patients with organ impairment or obesity. ( Sclar, DA, 2015) |
| "We carried out a retrospective investigation on the effect of obesity on dexmedetomidine (DEX) requirements when administered with fentanyl (FEN) during mechanical ventilation after major surgeries." | 7.81 | THE EFFECT OF OBESITY ON DOSE OF DEXMEDETOMIDINE WHEN ADMINISTERED WITH FENTANYL DURING POSTOPERATIVE MECHANICAL VENTILATION--RETROSPECTIVE. ( Hakozaki, T; Hosono, A; Imaizumi, T; Iseki, Y; Isosu, T; Mogami, M; Morimoto, I; Murakawa, M; Nakano, Y; Obara, S; Oishi, R, 2015) |
| " Children with obesity are commonly prescribed the opioids fentanyl and methadone, and accurate dosing is critical to reducing the risk of serious adverse events associated with overexposure." | 5.72 | Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity. ( Al-Uzri, A; Atz, AM; Carreño, FO; Delmore, P; Edginton, AN; Ford, JL; Gerhart, JG; Gonzalez, D; Muller, WJ; Perrin, EM; Watt, KM, 2022) |
| " One patient in the propofol group developed delirium compared to zero in desflurane." | 5.24 | The effect of desflurane versus propofol anesthesia on postoperative delirium in elderly obese patients undergoing total knee replacement: A randomized, controlled, double-blinded clinical trial. ( Goodman, S; Huddleston, J; Lemmens, HJ; Maloney, W; Sommer, BR; Tanaka, P, 2017) |
| "Actual body weight overestimates fentanyl dose requirements in obese patients." | 5.11 | Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight ("pharmacokinetic mass"). ( Bairamian, M; Inchiosa, MA; Sawada, K; Shibutani, K, 2004) |
| "Remifentanil in combination with fentanyl is used less than fentanyl in surgical patients with hepatic impairment or obesity." | 3.81 | Remifentanil, fentanyl, or the combination in surgical procedures in the United States: predictors of use in patients with organ impairment or obesity. ( Sclar, DA, 2015) |
| "We carried out a retrospective investigation on the effect of obesity on dexmedetomidine (DEX) requirements when administered with fentanyl (FEN) during mechanical ventilation after major surgeries." | 3.81 | THE EFFECT OF OBESITY ON DOSE OF DEXMEDETOMIDINE WHEN ADMINISTERED WITH FENTANYL DURING POSTOPERATIVE MECHANICAL VENTILATION--RETROSPECTIVE. ( Hakozaki, T; Hosono, A; Imaizumi, T; Iseki, Y; Isosu, T; Mogami, M; Morimoto, I; Murakawa, M; Nakano, Y; Obara, S; Oishi, R, 2015) |
| "We previously proposed dosing weights for fentanyl, termed 'pharmacokinetic mass', that span the total body weight (TBW) range from 40 to 210 kg." | 3.73 | Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. ( Bairamian, M; Inchiosa, MA; Sawada, K; Shibutani, K, 2005) |
| "To investigate the relationship between total body weight (TBW) or body mass index (BMI) and atracurium reversal time." | 3.70 | Antagonism of atracurium-induced block in obese patients. ( Kirkegaard-Nielsen, H; Lindholm, P; Petersen, HS; Severinsen, IK, 1998) |
| "Ketamine treatment was associated with significantly lower NRS scores and morphine doses." | 3.30 | Perioperative use of ketamine infusion versus dexmedetomidine infusion for analgesia in obese patients undergoing bariatric surgery: a double-blinded three-armed randomized controlled trial. ( Ali, BEEH; El-Shaer, AN; Elderh, MSH; Khaja, MAR; Khalil, BNM; Taeimah, MOA, 2023) |
| "Fentanyl was the opioid used in the OCA group." | 3.11 | A comparison of opioid-containing anesthesia versus opioid-free anesthesia using the Cortínez-Sepúlveda model on differential cytokine responses in obese patients undergoing gastric bypass surgery: a randomized controlled trial. ( Campos-Pérez, W; Cuevas, JHM; González-Landeros, D; Martínez-López, E; Pérez-Robles, M; Pérez-Vargas, L; Ramírez-Plascencia, L; Rivera-Valdés, JJ; Sánchez-Muñoz, P, 2022) |
| " Important pharmacokinetic differences between alfentanil, fentanyl and sufentanil have been shown in many reports." | 2.39 | Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. ( Scholz, J; Schulz, M; Steinfath, M, 1996) |
| "Fentanyl is a highly lipophilic mu opioid receptor agonist, increasingly found in heroin and other drug supplies, that is contributing to marked increases in opioid-related overdose and may be complicating treatment of opioid use disorder (OUD)." | 1.91 | Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance. ( Choi, CJ; Comer, S; Jones, J; Luba, R, 2023) |
| "A pharmacokinetic simulation study." | 1.51 | Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. ( Henry, ED; Johnson, PN; Lim, SY; Miller, JL; Skrepnek, GH; Woo, S, 2019) |
| "The relationship between initial fentanyl infusion dosage and time to goal sedation in nonobese and obese critically ill children was examined." | 1.46 | Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children. ( Golding, CL; Johnson, PN; Miller, JL; Owora, AH; Skrepnek, GH; Thomas, AN, 2017) |
| " Sedative and analgesic dosing was not clinically significantly higher in obese patients than in non-obese patients." | 1.43 | Sedation for Bronchoscopy and Complications in Obese Patients. ( Bellinger, CR; Chatterjee, AB; Haponik, E; Khan, I, 2016) |
| "The aim of this study is to assess the prevalence of sedation-related adverse events and the independent predictors of sedation requirements in RYGB patients." | 1.40 | Conscious sedation for upper endoscopy in the gastric bypass patient: prevalence of cardiopulmonary adverse events and predictors of sedation requirement. ( Abu Dayyeh, BK; Jirapinyo, P; Thompson, CC, 2014) |
| " Further studies are necessary to confirm these findings in order to determine adequate local anaesthetic dosing for thoracic epidural analgesia in obese patients." | 1.39 | Postoperative epidural analgesia in obese patients undergoing liver resection surgery. ( Bellamy, M; Biercamp, C; Hudson-Phillips, S; Kocarev, M; Milan, Z; Pane, H; Procter, H; Rajasekar, N; Simpson, R, 2013) |
| " Calculation of pharmacokinetic variables from the derived compartmental models demonstrated an increased volume of distribution of sufentanil in the obese (9098 +/- 2793 mL/kg ideal body weight, mean +/- SD) when compared with a control group (5073 +/- 1673 mL/kg ideal body weight) (P less than 0." | 1.28 | Pharmacokinetics of sufentanil in obese patients. ( Matteo, RS; Myers, KJ; Ornstein, E; Schwartz, AE; Young, WL, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (23.81) | 18.7374 |
| 1990's | 6 (14.29) | 18.2507 |
| 2000's | 7 (16.67) | 29.6817 |
| 2010's | 14 (33.33) | 24.3611 |
| 2020's | 5 (11.90) | 2.80 |
| Authors | Studies |
|---|---|
| Gerhart, JG | 1 |
| Carreño, FO | 1 |
| Ford, JL | 1 |
| Edginton, AN | 1 |
| Perrin, EM | 1 |
| Watt, KM | 1 |
| Muller, WJ | 1 |
| Atz, AM | 1 |
| Al-Uzri, A | 1 |
| Delmore, P | 1 |
| Gonzalez, D | 1 |
| Campos-Pérez, W | 1 |
| Ramírez-Plascencia, L | 1 |
| Pérez-Robles, M | 1 |
| Rivera-Valdés, JJ | 1 |
| Sánchez-Muñoz, P | 1 |
| Pérez-Vargas, L | 1 |
| González-Landeros, D | 1 |
| Cuevas, JHM | 1 |
| Martínez-López, E | 1 |
| Luba, R | 3 |
| Jones, J | 3 |
| Choi, CJ | 3 |
| Comer, S | 3 |
| Khalil, BNM | 1 |
| Elderh, MSH | 1 |
| Khaja, MAR | 1 |
| El-Shaer, AN | 1 |
| Ali, BEEH | 1 |
| Taeimah, MOA | 1 |
| Verkerk, BS | 1 |
| Dzierba, AL | 1 |
| Muir, J | 1 |
| Der-Nigoghossian, C | 1 |
| Brodie, D | 1 |
| Bacchetta, M | 1 |
| Rietdijk, W | 1 |
| Bakker, J | 1 |
| Lim, SY | 1 |
| Woo, S | 1 |
| Miller, JL | 2 |
| Skrepnek, GH | 2 |
| Henry, ED | 1 |
| Johnson, PN | 2 |
| Tang, C | 1 |
| Poloyac, SM | 1 |
| Tanaka, P | 1 |
| Goodman, S | 1 |
| Sommer, BR | 1 |
| Maloney, W | 1 |
| Huddleston, J | 1 |
| Lemmens, HJ | 1 |
| Golding, CL | 1 |
| Owora, AH | 1 |
| Thomas, AN | 1 |
| Horwitz, G | 1 |
| Roncari, D | 1 |
| Braaten, KP | 1 |
| Maurer, R | 1 |
| Fortin, J | 1 |
| Goldberg, AB | 1 |
| Li, L | 1 |
| Feng, J | 1 |
| Xie, SH | 1 |
| Geng, LC | 1 |
| Jirapinyo, P | 1 |
| Abu Dayyeh, BK | 1 |
| Thompson, CC | 1 |
| Sclar, DA | 1 |
| Obara, S | 1 |
| Morimoto, I | 1 |
| Iseki, Y | 1 |
| Oishi, R | 1 |
| Mogami, M | 1 |
| Imaizumi, T | 1 |
| Hosono, A | 1 |
| Hakozaki, T | 1 |
| Nakano, Y | 1 |
| Isosu, T | 1 |
| Murakawa, M | 1 |
| Burghardt, PR | 1 |
| Rothberg, AE | 1 |
| Dykhuis, KE | 1 |
| Burant, CF | 1 |
| Zubieta, JK | 1 |
| Tuominen, L | 1 |
| Tuulari, J | 1 |
| Karlsson, H | 1 |
| Hirvonen, J | 1 |
| Helin, S | 1 |
| Salminen, P | 1 |
| Parkkola, R | 1 |
| Hietala, J | 1 |
| Nuutila, P | 1 |
| Nummenmaa, L | 1 |
| Khan, I | 1 |
| Chatterjee, AB | 1 |
| Bellinger, CR | 1 |
| Haponik, E | 1 |
| Ngaka, TC | 1 |
| Coetzee, JF | 1 |
| Dyer, RA | 1 |
| Milan, Z | 1 |
| Rajasekar, N | 1 |
| Hudson-Phillips, S | 1 |
| Pane, H | 1 |
| Procter, H | 1 |
| Simpson, R | 1 |
| Kocarev, M | 1 |
| Biercamp, C | 1 |
| Bellamy, M | 1 |
| Lim, Y | 1 |
| Loo, CC | 1 |
| Goh, E | 1 |
| Shibutani, K | 2 |
| Inchiosa, MA | 2 |
| Sawada, K | 2 |
| Bairamian, M | 2 |
| George, R | 1 |
| Poonnoose, P | 1 |
| Isaiah, R | 1 |
| Cillo, JE | 1 |
| Finn, R | 1 |
| Varela, C | 1 |
| Palacio, F | 1 |
| Reina, MA | 1 |
| López, A | 1 |
| Benito-León, J | 1 |
| Bentley, JB | 2 |
| Vaughan, RW | 2 |
| Cork, RC | 2 |
| Gandolfi, AJ | 1 |
| Lawson, R | 1 |
| Hickey, S | 1 |
| Scholz, J | 1 |
| Steinfath, M | 1 |
| Schulz, M | 1 |
| Kirkegaard-Nielsen, H | 1 |
| Lindholm, P | 1 |
| Petersen, HS | 1 |
| Severinsen, IK | 1 |
| Dilger, JA | 1 |
| Tetzlaff, JE | 1 |
| Bell, GR | 1 |
| Kosmorsky, GS | 1 |
| Agnor, RC | 1 |
| O'Hara, JF | 1 |
| Ghabash, M | 1 |
| Choueiry, P | 1 |
| Matta, M | 1 |
| Kafer, ER | 1 |
| Marsh, HM | 1 |
| Söderberg, M | 1 |
| Thomson, D | 1 |
| White, T | 1 |
| Linderkamp, O | 1 |
| Dehnert-Hilscher, A | 1 |
| Drumheller, GH | 1 |
| Schwartz, AE | 1 |
| Matteo, RS | 1 |
| Ornstein, E | 1 |
| Young, WL | 1 |
| Myers, KJ | 1 |
| Esclamado, RM | 1 |
| Glenn, MG | 1 |
| McCulloch, TM | 1 |
| Cummings, CW | 1 |
| Lessing, AJ | 1 |
| De Kock, MJ | 1 |
| McIntyre, JW | 1 |
| Fregnan, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care[NCT01431326] | 3,520 participants (Actual) | Observational | 2011-11-30 | Completed | |||
| A Comparison of Opioid-containing Anesthesia Versus Opioid-free Anesthesia Using the Cortínez-Sepúlveda Model on Differential Cytokine Responses in Patients Undergoing Gastric Bypass Surgery[NCT04854252] | 40 participants (Actual) | Interventional | 2020-11-12 | Completed | |||
| Effectiveness of Subarachnoid Hyperbaric Bupivacaine on Mean Arterial Blood Pressure in Pregnant Patients With Obesity Operated by Cesarean Section[NCT04205344] | Phase 4 | 40 participants (Actual) | Interventional | 2017-02-01 | Completed | ||
| Effect of Subarachnoid Hyperbaric Bupivacaine on Mean Arterial Pressure in Obese Pregnant Patients Undergoing Cesarean Section[NCT06060015] | Phase 4 | 106 participants (Anticipated) | Interventional | 2023-08-01 | Recruiting | ||
| Evaluation of Treatment Effect of Cervical Collar in Moderate Obstructive Sleep Apnea[NCT03754270] | 100 participants (Actual) | Interventional | 2019-06-16 | Completed | |||
| The Association of CPAP Compliance and Nocturnal Hypoxemia in the Perioperative Period[NCT02796846] | 158 participants (Actual) | Observational | 2015-06-30 | Completed | |||
| Evaluation of Screening Tools for OSA in Hospitalized Medical Patients: A Validation Study[NCT01340781] | 110 participants (Actual) | Observational | 2012-02-29 | Completed | |||
| The Effect of Acute Intravenous Morphine Administration on Sleep Disordered Breathing (SDB) in Patients With Moderate Obstructive Sleep Apnoea (OSA): A Paired Design Trial[NCT03127800] | Phase 3 | 6 participants (Actual) | Interventional | 2016-05-20 | Terminated (stopped due to Difficulties with recruitment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for fentanyl and Obesity
| Article | Year |
|---|---|
Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
Topics: Aging; Alfentanil; Analgesics, Opioid; Fentanyl; Half-Life; Humans; Obesity; Sufentanil | 1996 |
6 trials available for fentanyl and Obesity
35 other studies available for fentanyl and Obesity
| Article | Year |
|---|---|
Use of physiologically-based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity.
Topics: Adult; Analgesics, Opioid; Child; Fentanyl; Humans; Methadone; Obesity | 2022 |
Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance.
Topics: Analgesics, Opioid; Animals; Body Mass Index; Cattle; Female; Fentanyl; Morphine; Narcotic Antagonis | 2023 |
Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance.
Topics: Analgesics, Opioid; Animals; Body Mass Index; Cattle; Female; Fentanyl; Morphine; Narcotic Antagonis | 2023 |
Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance.
Topics: Analgesics, Opioid; Animals; Body Mass Index; Cattle; Female; Fentanyl; Morphine; Narcotic Antagonis | 2023 |
Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance.
Topics: Analgesics, Opioid; Animals; Body Mass Index; Cattle; Female; Fentanyl; Morphine; Narcotic Antagonis | 2023 |
Opioid and Benzodiazepine Requirements in Obese Adult Patients Receiving Extracorporeal Membrane Oxygenation.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Extracorporeal Membrane Oxygenation; Female; Fentanyl; H | 2020 |
Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children.
Topics: Adolescent; Body Mass Index; Child; Child, Preschool; Computer Simulation; Female; Fentanyl; Humans; | 2019 |
A Modeling-Based Approach to Estimate Fentanyl Pharmacokinetics in Obese Critically Ill Children.
Topics: Child; Critical Illness; Fentanyl; Humans; Infusions, Intravenous; Obesity | 2019 |
Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children.
Topics: Adolescent; Anesthetics, Intravenous; Child; Child, Preschool; Cohort Studies; Critical Illness; Fem | 2017 |
Moderate intravenous sedation for first trimester surgical abortion: a comparison of adverse outcomes between obese and normal-weight women.
Topics: Abortion, Induced; Adolescent; Adult; Anesthetics, Intravenous; Body Mass Index; Child; Conscious Se | 2018 |
A chin-lift mask produces a patent airway more effectively than an oropharyngeal airway using the EC-clamp technique in obese patients.
Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Atracurium; Chin; Cholecystectomy; Cholecystit | 2014 |
Conscious sedation for upper endoscopy in the gastric bypass patient: prevalence of cardiopulmonary adverse events and predictors of sedation requirement.
Topics: Adult; Anesthetics, Intravenous; Arrhythmias, Cardiac; Body Mass Index; Conscious Sedation; Endoscop | 2014 |
Remifentanil, fentanyl, or the combination in surgical procedures in the United States: predictors of use in patients with organ impairment or obesity.
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Intravenous; Drug Therapy, Combination; Female; Fentan | 2015 |
THE EFFECT OF OBESITY ON DOSE OF DEXMEDETOMIDINE WHEN ADMINISTERED WITH FENTANYL DURING POSTOPERATIVE MECHANICAL VENTILATION--RETROSPECTIVE.
Topics: Body Mass Index; Body Weight; Dexmedetomidine; Fentanyl; Humans; Obesity; Respiration, Artificial; R | 2015 |
Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.
Topics: Adult; Brain; Caloric Restriction; Carbon Radioisotopes; Case-Control Studies; Eating; Fasting; Fent | 2015 |
Aberrant mesolimbic dopamine-opiate interaction in obesity.
Topics: Adult; Body Mass Index; Caudate Nucleus; Female; Fentanyl; Humans; Middle Aged; Obesity; Positron-Em | 2015 |
Sedation for Bronchoscopy and Complications in Obese Patients.
Topics: Anesthetics, Intravenous; Body Mass Index; Bronchoscopy; Conscious Sedation; Female; Fentanyl; Human | 2016 |
The Influence of Body Mass Index on Sensorimotor Block and Vasopressor Requirement During Spinal Anesthesia for Elective Cesarean Delivery.
Topics: Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Body Mas | 2016 |
The Influence of Body Mass Index on Sensorimotor Block and Vasopressor Requirement During Spinal Anesthesia for Elective Cesarean Delivery.
Topics: Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Body Mas | 2016 |
The Influence of Body Mass Index on Sensorimotor Block and Vasopressor Requirement During Spinal Anesthesia for Elective Cesarean Delivery.
Topics: Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Body Mas | 2016 |
The Influence of Body Mass Index on Sensorimotor Block and Vasopressor Requirement During Spinal Anesthesia for Elective Cesarean Delivery.
Topics: Adult; Analgesics, Opioid; Anesthesia, Obstetrical; Anesthesia, Spinal; Anesthetics, Local; Body Mas | 2016 |
Postoperative epidural analgesia in obese patients undergoing liver resection surgery.
Topics: Aged; Analgesia, Epidural; Anesthesia, General; Anesthetics; Body Mass Index; Bupivacaine; Drug Ther | 2013 |
Ultra low dose combined spinal and epidural anesthesia for cesarean section.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, Spinal; Ane | 2004 |
[Should the dosage of fentanyl be based on the body weight when the patient is obese? A proposal of the appropriate "pharmacokinetic body mass"].
Topics: Analgesics, Opioid; Anesthetics, Intravenous; Body Weight; Fentanyl; Humans; Obesity | 2004 |
Dercum's disease (Adiposis dolorosa): delayed diagnosis in a patient with cervical cancer.
Topics: Adiposis Dolorosa; Adult; Amitriptyline; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antide | 2004 |
Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Anthropometry; Body Weight; Dose-Response Relati | 2005 |
Correlation and comparison of body mass index on hemodynamics in hypertensive and normotensive patients undergoing intravenous sedation.
Topics: Adult; Anesthesia, Dental; Anesthetics, Intravenous; Blood Pressure; Body Mass Index; Conscious Seda | 2006 |
[Horner's syndrome secondary to epidural anesthesia].
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthetics, Local; Arm; Bupivacaine; Cesarean | 2007 |
Puncture of the laryngeal mask airway cuff.
Topics: Airway Obstruction; Anesthesia, Intravenous; Fentanyl; Humans; Laryngeal Masks; Male; Obesity; Propo | 1994 |
Antagonism of atracurium-induced block in obese patients.
Topics: Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Atracurium; Body Mass Index; Body Weight; | 1998 |
Ischaemic optic neuropathy after spinal fusion.
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intravenous; Blood Loss, Surgi | 1998 |
Aspirated air capnography with esophageal detector device to confirm tracheal intubation in rapid sequence induction.
Topics: Adolescent; Adult; Aged; Anesthesia, Intravenous; Anesthetics, Intravenous; Capnography; Carbon Diox | 1998 |
The effects of anesthetic drugs and disease on the chemical regulation of ventilation.
Topics: Anesthetics; Anti-Anxiety Agents; Autonomic Nervous System; Barbiturates; Benzodiazepines; Carbon Di | 1977 |
Respiration, circulation and anaesthetic management in obesity. Investigation before and after jejunoileal bypass.
Topics: Adult; Aged; Alcuronium; Anesthesia, General; Blood Circulation; Blood Pressure; Blood Volume; Carbo | 1977 |
[The influence of neuroleptanalgesia on blood volume and circulatory pressures (author's transl)].
Topics: Aged; Blood Pressure; Blood Volume; Central Venous Pressure; Droperidol; Female; Fentanyl; Hematocri | 1977 |
Extranasal treatment of epistaxis.
Topics: Age Factors; Antihypertensive Agents; Chlorothiazide; Droperidol; Drug Combinations; Epistaxis; Fent | 1975 |
Pharmacokinetics of sufentanil in obese patients.
Topics: Adult; Analgesics; Female; Fentanyl; Half-Life; Humans; Injections, Intravenous; Male; Middle Aged; | 1991 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Perioperative complications and risk factors in the surgical treatment of obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Airway Obstruction; Arrhythmias, Cardiac; Chi-Square Distribution; Fem | 1989 |
Anaesthesia in a grossly obese patient: a case report.
Topics: Abdomen, Acute; Anesthesia, Intravenous; Arrhythmias, Cardiac; Cholecystitis; Female; Fentanyl; Huma | 1968 |
Problems for the anaesthetist in the care of the obese patient.
Topics: Anesthesia, General; Blood Pressure Determination; Body Height; Body Weight; Fentanyl; Halothane; Hu | 1968 |
[Physiopathologic, clinical and anesthesiologic considerations on gynecologic surgery in obese patients. Our experience with neuroleptoanalgesia].
Topics: Anesthesia; Benperidol; Female; Fentanyl; Genital Diseases, Female; Genital Neoplasms, Female; Human | 1968 |